Pancreatic Cancer Research

ResearcherKagoshima UniversityNo recent work listed

Ken Sasaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7305-0354; OpenAlex author ID A5046798526. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers

Papers 3

  1. Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5. Co-author DOI 10.1038/s41416-020-01093-z↗
  2. Effectiveness of Adjuvant Therapy in Patients with Pancreatic Cancer Who Underwent Neoadjuvant Therapy. Co-author DOI 10.1245/s10434-021-09712-6↗
  3. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer. Co-author DOI 10.1007/s10585-017-9840-3↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroshi Kurahara · 2 shared papers, 2017–2021 · strength 0.21
  2. Eric D Young · 2 shared papers, 2017–2021 · strength 0.19
  3. Danny R. Welch · 2 shared papers, 2017–2021 · strength 0.19
  4. Tetsuya Idichi · 1 shared paper, 2021 · strength 0.13
  5. Yuko Mataki · 1 shared paper, 2021 · strength 0.13
  6. Takao Ohtsuka · 1 shared paper, 2021 · strength 0.13
  7. Sharon Manley · 1 shared paper, 2021 · strength 0.11
  8. Michael Anthony Hollingsworth · 1 shared paper, 2021 · strength 0.11
  9. Paul M. Grandgenett · 1 shared paper, 2021 · strength 0.11
  10. Shoji Natsugoe · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.